Research ArticleA comparative study of the single crystal X-ray determination and molecular modelling of the binding of OLIGOMYCIN (cas 1404-19-9) to ATP Synthase
-
Add time:09/06/2019 Source:sciencedirect.com
Recently published X-ray structures of three common forms, A, B and C, of OLIGOMYCIN (cas 1404-19-9), including absolute configurations, are investigated to examine their binding to ATP Synthase. The X-ray studies reveal regions with differences in three-dimensional structure and hydrogen bonding propensity between the oligomycins, which may be associated with their potential to bind to sites on ATP Synthase. Computational docking studies carried out using MOE with the X-ray structures and an homology model of the FO domain of ATP Synthase from Escherichia coli, are used to derive an induced fit pocket. Docking of all oligomycins to this pocket indicate that the B and C forms bind more tightly than the A form. Consideration of the single crystal X-ray data alone indicate the B form may be the best inhibitor and that O(24) is the most important ligating group for binding, this is supported by the docking data. The latter reveals Asn214 and other key proton translocating residues to be the main residues contacted by the inhibitor. These data allow the binding modes of different forms of oligomycin to be deduced from X-ray single crystal data supported by molecular modelling and computational docking studies.
We also recommend Trading Suppliers and Manufacturers of OLIGOMYCIN (cas 1404-19-9). Pls Click Website Link as below: cas 1404-19-9 suppliers
Prev:Full PaperOLIGOMYCIN (cas 1404-19-9), an F1FO-ATPase Inhibitor, Protects Against Ischemic Acute Kidney Injury in Male but Not in Female Rats
Next:OLIGOMYCIN (cas 1404-19-9) A and the IPLB-LdFB insect cell line: Actin and mitochondrial responses) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from OLIGOMYCIN (cas 1404-19-9) A09/08/2019
- OLIGOMYCIN (cas 1404-19-9) A and the IPLB-LdFB insect cell line: Actin and mitochondrial responses09/07/2019
- Full PaperOLIGOMYCIN (cas 1404-19-9), an F1FO-ATPase Inhibitor, Protects Against Ischemic Acute Kidney Injury in Male but Not in Female Rats09/05/2019
- Research paperThe mitochondrial F1FO-ATPase desensitization to OLIGOMYCIN (cas 1404-19-9) by tributyltin is due to thiol oxidation09/04/2019
- Original article/Article originalOLIGOMYCIN (cas 1404-19-9)s A and E, major bioactive secondary metabolites produced by Streptomyces sp. strain HG29 isolated from a Saharan soil09/03/2019
- Synthesis and cytotoxicity of OLIGOMYCIN (cas 1404-19-9) A derivatives modified in the side chain09/02/2019
- ReviewModifiers of the OLIGOMYCIN (cas 1404-19-9) sensitivity of the mitochondrial F1F0-ATPase09/01/2019


